ABBOTT LABORATORIES (ABT) Total liabilities 2016–2025
ABBOTT LABORATORIES (ABT) total liabilities at each fiscal year-end, per SEC filings.
$34.6BFY2025 · since FY2016: $32.1B → $34.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $34.6B | +2.5% |
| FY2024 | $33.8B | -2.5% |
| FY2023 | $34.6B | -8.3% |
| FY2022 | $37.8B | -4.2% |
| FY2021 | $39.4B | -0.9% |
| FY2020 | $39.8B | +8.1% |
| FY2019 | $36.8B | +0.4% |
| FY2018 | $36.6B | -19.2% |
| FY2017 | $45.4B | +41.2% |
| FY2016 | $32.1B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice